Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Bernardi

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Targets|October 23, 2018
HIF-α factors as potential therapeutic targets in leukemiaDaniela Magliulo, Rosa Bernardi
Cell Research|May 10, 2014
Hallmarks of triple negative breast cancer emerging at last?Rosa Bernardi, Luca Gianni
Frontiers in Oncology|September 5, 2022
Hypoxic stress and hypoxia-inducible factors in leukemiasDaniela Magliulo, Rosa Bernardi
Frontiers in Oncology|February 28, 2014
A Dialog on the First 20 Years of PML Research and the Next 20 AheadRosa Bernardi, Pier Paolo Pandolfi
Nature Reviews. Molecular Cell Biology|October 12, 2007
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodiesRosa Bernardi, Pier Paolo Pandolfi
Oncogene|December 10, 2003
Role of PML and the PML-nuclear body in the control of programmed cell deathRosa Bernardi, Pier Paolo Pandolfi
Frontiers in Oncology|August 4, 2018
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid LeukemiaDaniela Magliulo, Rosa Bernardi, Samantha Messina
Current Opinion in Genetics & Development|February 14, 2009
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cellKeisuke Ito, Rosa Bernardi, Pier Paolo Pandolfi
Oncogene|May 29, 2002
Modelling haematopoietic malignancies in the mouse and therapeutical implicationsRosa Bernardi, Silvia Grisendi, Pier Paolo Pandolfi
Trends in Biochemical Sciences|March 2, 2022
PML isoforms: a molecular basis for PML pleiotropic functionsMartina Uggè, Matilde Simoni, Cristina Fracassi, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Targets|October 23, 2018
HIF-α factors as potential therapeutic targets in leukemiaDaniela Magliulo, Rosa Bernardi
Cell Research|May 10, 2014
Hallmarks of triple negative breast cancer emerging at last?Rosa Bernardi, Luca Gianni
Frontiers in Oncology|September 5, 2022
Hypoxic stress and hypoxia-inducible factors in leukemiasDaniela Magliulo, Rosa Bernardi
Frontiers in Oncology|February 28, 2014
A Dialog on the First 20 Years of PML Research and the Next 20 AheadRosa Bernardi, Pier Paolo Pandolfi
Nature Reviews. Molecular Cell Biology|October 12, 2007
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodiesRosa Bernardi, Pier Paolo Pandolfi
Oncogene|December 10, 2003
Role of PML and the PML-nuclear body in the control of programmed cell deathRosa Bernardi, Pier Paolo Pandolfi
Frontiers in Oncology|August 4, 2018
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid LeukemiaDaniela Magliulo, Rosa Bernardi, Samantha Messina
Current Opinion in Genetics & Development|February 14, 2009
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cellKeisuke Ito, Rosa Bernardi, Pier Paolo Pandolfi
Oncogene|May 29, 2002
Modelling haematopoietic malignancies in the mouse and therapeutical implicationsRosa Bernardi, Silvia Grisendi, Pier Paolo Pandolfi
Trends in Biochemical Sciences|March 2, 2022
PML isoforms: a molecular basis for PML pleiotropic functionsMartina Uggè, Matilde Simoni, Cristina Fracassi, et al.
Pageof 5